{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T20:29:37Z","timestamp":1648672177391},"reference-count":10,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.medcli.2015.10.002","type":"journal-article","created":{"date-parts":[[2015,11,14]],"date-time":"2015-11-14T22:00:22Z","timestamp":1447538422000},"page":"416-417","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hiperparatiroidismo en el s\u00edndrome de neoplasia endocrina m\u00faltiple tipo 2A. Implicaciones terap\u00e9uticas y gen\u00e9ticas"],"prefix":"10.1016","volume":"146","author":[{"given":"Beatriz","family":"Febrero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 M.","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"R\u00edos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascual","family":"Parrilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2015.10.002_bib0055","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/110241501750099294","article-title":"Long-term biochemical results after operative treatment of primary hyperparathyroidism associated with multiple endocrine neoplasia types I and IIa: Is a more or less extended operation essential","volume":"167","author":"Dotzenrath","year":"2001","journal-title":"Eur J Surg"},{"key":"10.1016\/j.medcli.2015.10.002_bib0060","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s002689900123","article-title":"Primary hyperparathyroidism in multiple endocrine neoplasia type IIa: Retrospective French multicentric study. Groupe d\u2019Etude des Tumeurs a Calcitonine (GETC, French Calcitonin Tumors Study Group), French Association of Endocrine Surgeons","volume":"20","author":"Kraimps","year":"1996","journal-title":"World J Surg"},{"key":"10.1016\/j.medcli.2015.10.002_bib0065","first-page":"1031","article-title":"Surgical management of primary hyperparathyroidism in multiple endocrine neoplasia types 1 and 2","volume":"114","author":"O\u2019Riordain","year":"1993","journal-title":"Surgery"},{"key":"10.1016\/j.medcli.2015.10.002_bib0070","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJM198605153142004","article-title":"Parathyroid mitogenic activity in plasma from familial multiple endocrine neoplasia type I","volume":"314","author":"Brandi","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2015.10.002_bib0075","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4158\/EP10050.OR","article-title":"Evolution of surgical treatment of primary hyperparathyroidism in patients with multiple endocrine neoplasia type 2A","volume":"17","author":"Scholten","year":"2011","journal-title":"Endocr Pract"},{"key":"10.1016\/j.medcli.2015.10.002_bib0080","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1530\/EJE-14-0818","article-title":"RET Cys634Arg mutation confers a more aggressive multiple endocrine neoplasia type 2A phenotype than Cys634Tyr mutation","volume":"172","author":"Vald\u00e9s","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.medcli.2015.10.002_bib0085","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","article-title":"Guidelines for diagnosis and therapy of MEN type 1 and type 2","volume":"86","author":"Brandi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.medcli.2015.10.002_bib0090","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1750-1172-8-50","article-title":"Differences between sporadic and MEN related primary hyperparathyroidism; clinical expression, preoperative workup, operative strategy and follow-up","volume":"8","author":"Twigt","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.medcli.2015.10.002_bib0095","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/ng0194-70","article-title":"Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC","volume":"6","author":"Mulligan","year":"1994","journal-title":"Nat Genet"},{"key":"10.1016\/j.medcli.2015.10.002_bib0100","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1210\/jc.2002-021422","article-title":"RET codon 634 mutations in multiple endocrine neoplasia type 2: variable clinical features and clinical outcome","volume":"88","author":"Pu\u00f1ales","year":"2003","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775315005254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775315005254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T18:21:45Z","timestamp":1537208505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775315005254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0025775315005254"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2015.10.002","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hiperparatiroidismo en el s\u00edndrome de neoplasia endocrina m\u00faltiple tipo 2A. Implicaciones terap\u00e9uticas y gen\u00e9ticas","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2015.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}